Answers are grounded in this paper and cite their sources.
Purpose Platelet‐rich plasma (PRP) has been widely investigated as a biologic adjunct in arthroscopic rotator cuff repair (ARCR), yet clinical evidence remains heterogeneous. One potential source of variability is the timing of PRP administration, which may influence tendon‐to‐bone healing. This study aimed to evaluate the effect of PRP augmentation on structural healing and clinical outcomes following ARCR, with particular evaluation of outcomes according to the timing of PRP administration. Methods A systematic review was conducted in accordance with PRISMA guidelines and registered on PROSPERO. PubMed, Scopus, Cochrane CENTRAL and Web of Science were searched through 19 February 2026. Randomised controlled trials (RCTs) comparing PRP augmentation with control in adult patients undergoing ARCR were included. Trials were stratified by timing of PRP administration (intraoperative, post‐operative‐only or combined). The primary outcome was retears assessed by post‐operative imaging at ≥6 months. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random‐effects model. Heterogeneity was assessed using I 2 statistics. Results Fifteen RCTs (1214 patients; 647 PRP and 567 control) met inclusion criteria. Overall, PRP administration at ≥6 months was associated with a reduced risk of retears (RR, 0.53; 95% CI, 0.40–0.70; p < 0.001; I 2 = 0%). Subgroup analysis demonstrated that intraoperative PRP significantly reduced retear rates at ≥6 months (RR, 0.49; 95% CI, 0.35–0.68; p < 0.001; I 2 = 0%) and ≥12 months (RR, 0.52; 95% CI, 0.30–0.91; p = 0.021; I 2 = 0%). Post‐operative‐only PRP did not demonstrate a statistically significant reduction in retears (RR, 0.35; 95% CI, 0.01–8.12; p = 0.54). Absolute risk reduction at ≥6 months was approximately 12%, corresponding to a number needed to treat of 8. Functional outcome scores improved in both PRP and control groups, with significant differences between groups in included studies, but pooled analyses did not demonstrate consistent between‐group differences. PRP was not associated with increased complication rates. Conclusion Intraoperative PRP augmentation during ARCR is associated with a statistically significant reduction in retears. The limited post‐operative‐only PRP protocols do not demonstrate a comparable benefit and preclude a definitive conclusion that efficacy differs according to timing. These findings suggest a potential timing‐dependent structural effect of PRP. However, structural improvements did not consistently translate into superior functional outcomes. Level of Evidence Level I.
No takes yet. Share an insight, caveat, or question.
Tareen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: